Pre-procedural risk factors for contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention

被引:0
|
作者
Somaschini, A. [1 ,2 ]
Cornara, S. [1 ,2 ]
Crimi, G. [1 ]
Pica, S. [1 ]
Baldo, A. [1 ,2 ]
Repetto, A. [1 ]
Pavesi, C. [1 ,2 ]
Potenza, A. [1 ,2 ]
Camporotondo, R. [1 ]
De Ferrari, G. M. [1 ]
机构
[1] Fdn IRCCS Policlin San Matteo, Dept Cardiol, Pavia, Italy
[2] Univ Pavia, I-27100 Pavia, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1629
引用
收藏
页码:303 / 303
页数:1
相关论文
共 50 条
  • [41] REPLY: Effect of Pre-Procedural β-Blocker in Patients Undergoing Percutaneous Coronary Intervention
    Motivala, Apurva A.
    Parikh, Valay
    Roe, Matthew
    Dai, David
    Abbott, J. Dawn
    Prasad, Abhiram
    Mukherjee, Debabrata
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (23) : 2459 - 2460
  • [42] Neutrophil-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention
    Kaya, Ahmet
    Kaya, Yasemin
    Topcu, Selim
    Gunaydin, Zeki Yuksel
    Kurt, Mustafa
    Tanboga, Ibrahim Halil
    Kalkan, Kamuran
    Aksakal, Enbiya
    ANGIOLOGY, 2014, 65 (01) : 51 - 56
  • [43] Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
    Zhang, H.
    Fu, H.
    Fu, X.
    Zhang, J.
    Zhang, P.
    Yang, S.
    Zeng, Z.
    Fu, N.
    Guo, Z.
    BMC NEPHROLOGY, 2021, 22 (01)
  • [44] Glycosylated hemoglobin levels and the risk for contrast-induced nephropathy in diabetic patients undergoing coronary arteriography/percutaneous coronary intervention
    H. Zhang
    H. Fu
    X. Fu
    J. Zhang
    P. Zhang
    S. Yang
    Z. Zeng
    N. Fu
    Z. Guo
    BMC Nephrology, 22
  • [45] Acute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary intervention
    Marenzi, Giancarlo
    De Metrio, Monica
    Rubino, Mara
    Lauri, Gianfranco
    Cavallero, Annalisa
    Assanelli, Emilio
    Grazi, Marco
    Moltrasio, Marco
    Marana, Ivana
    Campodonico, Jeness
    Discacciati, Andrea
    Veglia, Fabrizio
    Bartorelli, Antonio L.
    AMERICAN HEART JOURNAL, 2010, 160 (06) : 1170 - 1177
  • [46] Blood Transfusion and the Risk of Contrast-Induced Nephropathy Among Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
    Karrowni, Wassef
    Vora, Amit N.
    Dai, Dadi
    Wojdyla, Daniel
    Dakik, Habib
    Rao, Sunil
    CIRCULATION, 2015, 132
  • [47] Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention
    Barbieri, Lucia
    Verdoia, Monica
    Schaffer, Alon
    Cassetti, Ettore
    Di Giovine, Gabriella
    Marino, Paolo
    Suryapranata, Harry
    De Luca, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 (03) : 458 - 464
  • [48] Evaluation of Emerging Predictors for Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention
    Gupta, Himanshu
    Singh, Mohit Mohan
    Sahani, Krishna Kumar
    Gupta, Ayushi
    Seth, Ganesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [49] Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention
    Chong, E.
    Shen, L.
    Poh, K. K.
    Tan, H. C.
    SINGAPORE MEDICAL JOURNAL, 2012, 53 (03) : 164 - 169
  • [50] Protection Against Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Ulus, Taner
    ANGIOLOGY, 2018, 69 (10) : 918 - 918